Abbott Laboratories CEO calls post-earnings stock decline 'a little bit of an overreaction'

  • Abbott Laboratories CEO Robert Ford unpacked his company's latest quarterly report in a Thursday interview with CNBC's Jim Cramer, saying that Wall Street's reaction to the results was too extreme. "I think this is a little bit of an overreaction.